Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.

Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal ...

Fewer people under age 50 are dying from cancer in the U.S., but colorectal cancer mortality rates continue to surge ...

Jones spoke to MHE after presenting research at the 2026 ASCO Gastrointestinal Cancers Symposium, held Jan. 8-10, in San ...

Predictive cancer diagnostics company Rhythm Biosciences has achieved a major milestone with the peer-reviewed validation of ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

The researchers examined the five leading causes of cancer death among the under-50 age group. They found that overall, from 1990 through 2023, more than 1.2 million people died of cancer in the ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

Colton Jones, M.D., of The University of Texas San Antonio, discusses aspirin for colorectal cancer prevention after presenting research comparing GLP-1s with aspirin at the 2026 ASCO Gastrointestinal ...

Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...

This will allow the hospital to focus on enhancing patient care and developing new detection tools and therapies. Read more at straitstimes.com. Read more at straitstimes.com.